Status:
ACTIVE_NOT_RECRUITING
The Young Women's Breast Cancer Study
Lead Sponsor:
Dana-Farber Cancer Institute
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-40 years
Brief Summary
The investigators are conducting a longitudinal cohort study of young women with breast cancer. The investigators identify women age 40 and younger with newly-diagnosed breast cancer from academic and...
Detailed Description
This is a longitudinal cohort study of young women with breast cancer. Over a 6-year period, the investigators aim to identify over 1,600 women age 40 and younger with newly diagnosed breast cancer fr...
Eligibility Criteria
Inclusion
- Female
- Diagnosis of breast cancer
- Age 40 or younger at diagnosis
- Informed consent obtained from patient
- Ability to understand written and spoken English to the extent necessary to complete the questionnaires
Exclusion
- Inability to understand written and spoken English to the extent necessary to complete the questionnaires
- Absence of informed consent
Key Trial Info
Start Date :
November 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2026
Estimated Enrollment :
1302 Patients enrolled
Trial Details
Trial ID
NCT01468246
Start Date
November 1 2006
End Date
January 1 2026
Last Update
April 22 2025
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Cancer Center
Aurora, Colorado, United States, 80045
2
Beth-Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
3
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215
4
Massachusetts General Hospital
Boston, Massachusetts, United States, 02215